Annual Total Liabilities
$208.50 M
-$15.60 M-6.96%
December 31, 2024
Summary
- As of February 26, 2025, TXG annual total liabilities is $208.50 million, with the most recent change of -$15.60 million (-6.96%) on December 31, 2024.
- During the last 3 years, TXG annual total liabilities has risen by +$7.24 million (+3.60%).
- TXG annual total liabilities is now -39.44% below its all-time high of $344.30 million, reached on December 31, 2018.
Performance
TXG Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$208.50 M
-$6.49 M-3.02%
December 31, 2024
Summary
- As of February 26, 2025, TXG quarterly total liabilities is $208.50 million, with the most recent change of -$6.49 million (-3.02%) on December 31, 2024.
- Over the past year, TXG quarterly total liabilities has dropped by -$6.49 million (-3.02%).
- TXG quarterly total liabilities is now -95.70% below its all-time high of $4.84 billion, reached on September 1, 2017.
Performance
TXG Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TXG Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.0% | -3.0% |
| 3 y3 years | +3.6% | -3.0% |
| 5 y5 years | +12.2% | -3.0% |
TXG Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.0% | +3.6% | -7.0% | +6.2% |
| 5 y | 5-year | -7.0% | +12.2% | -7.0% | +12.2% |
| alltime | all time | -39.4% | +12.2% | -95.7% | +48.6% |
10x Genomics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $208.50 M(-7.0%) | $208.50 M(-3.0%) |
| Sep 2024 | - | $214.99 M(+4.6%) |
| Jun 2024 | - | $205.61 M(+0.8%) |
| Mar 2024 | - | $204.08 M(-8.9%) |
| Dec 2023 | $224.10 M(+0.4%) | $224.10 M(+10.2%) |
| Sep 2023 | - | $203.32 M(+3.6%) |
| Jun 2023 | - | $196.34 M(-7.2%) |
| Mar 2023 | - | $211.65 M(-5.2%) |
| Dec 2022 | $223.24 M(+10.9%) | $223.24 M(+1.3%) |
| Sep 2022 | - | $220.41 M(+1.1%) |
| Jun 2022 | - | $218.07 M(+10.9%) |
| Mar 2022 | - | $196.57 M(-2.3%) |
| Dec 2021 | $201.26 M(+5.8%) | $201.26 M(+5.7%) |
| Sep 2021 | - | $190.35 M(-1.4%) |
| Jun 2021 | - | $192.99 M(-4.3%) |
| Mar 2021 | - | $201.57 M(+5.9%) |
| Dec 2020 | $190.27 M | $190.27 M(-12.5%) |
| Sep 2020 | - | $217.46 M(+13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $191.53 M(-4.9%) |
| Mar 2020 | - | $201.32 M(+8.3%) |
| Dec 2019 | $185.84 M(-46.0%) | $185.84 M(+22.8%) |
| Sep 2019 | - | $151.37 M(+7.9%) |
| Jun 2019 | - | $140.30 M(-59.3%) |
| Dec 2018 | $344.30 M(+83.0%) | $344.30 M(-92.9%) |
| Dec 2017 | $188.12 M | - |
| Sep 2017 | - | $4.84 B(+15.4%) |
| Jun 2017 | - | $4.20 B(+3.9%) |
| Mar 2017 | - | $4.04 B(+0.3%) |
| Dec 2016 | - | $4.03 B(-0.6%) |
| Sep 2016 | - | $4.05 B(+3.2%) |
| Jun 2016 | - | $3.92 B(-6.8%) |
| Mar 2016 | - | $4.21 B(+2.3%) |
| Dec 2015 | - | $4.12 B(-3.7%) |
| Sep 2015 | - | $4.28 B(+0.9%) |
| Jun 2015 | - | $4.24 B(+2.1%) |
| Mar 2015 | - | $4.15 B(-12.0%) |
| Dec 2014 | - | $4.71 B |
FAQ
- What is 10x Genomics annual total liabilities?
- What is the all time high annual total liabilities for 10x Genomics?
- What is 10x Genomics annual total liabilities year-on-year change?
- What is 10x Genomics quarterly total liabilities?
- What is the all time high quarterly total liabilities for 10x Genomics?
- What is 10x Genomics quarterly total liabilities year-on-year change?
What is 10x Genomics annual total liabilities?
The current annual total liabilities of TXG is $208.50 M
What is the all time high annual total liabilities for 10x Genomics?
10x Genomics all-time high annual total liabilities is $344.30 M
What is 10x Genomics annual total liabilities year-on-year change?
Over the past year, TXG annual total liabilities has changed by -$15.60 M (-6.96%)
What is 10x Genomics quarterly total liabilities?
The current quarterly total liabilities of TXG is $208.50 M
What is the all time high quarterly total liabilities for 10x Genomics?
10x Genomics all-time high quarterly total liabilities is $4.84 B
What is 10x Genomics quarterly total liabilities year-on-year change?
Over the past year, TXG quarterly total liabilities has changed by -$6.49 M (-3.02%)